A Study on Safety and Efficacy of Sodium-glucose Cotransporter-2 Inhibitors as Adjuvant to Insulin Add-on Therapy in Uncontrolled Type 2 Diabetic Patients. (2018). Asian Journal of Pharmaceutics (AJP), 12(03). https://doi.org/10.22377/ajp.v12i03.2625